50P Clinical impact of actionable molecular variants disclosed in late-stage cancer patients by tumor whole-exome sequencing in a prospective single-institution study

Autor: Mapendano, C.K., Nøhr, A.K., Carus, A., Lorincz, T., Oestergaard, L. Poulsen, Haslund, C.A., Pagh, A., Sønderkærd, M., Bøgsted, M., Pedersen, I.S., Ladekarl, M.

Publikováno v: In ESMO Open October 2023 8(1) Supplement 5

1508P Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis

Autor: Steiniche, M.M., Callesen, L.B., Vlk, E.H., Andersen, R.F., Hansen, T.F., Ladekarl, M., Spindler, K-L.G.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S923-S924

O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)

Autor: Pfeiffer, P., Yilmaz, M., Nordsmark, M., Möller, S., Elle, I., Ladekarl, M., Winther, S., Qvortrup, C., Baeksgaard, L.

Publikováno v: Pfeiffer, P, Yilmaz, M, Nordsmark, M, Möller, S, Elle, I, Ladekarl, M, Winther, S, Qvortrup, C & Baeksgaard, L 2022, ' O-4 Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophago-gastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas) ', Annals of Oncology, vol. 33, no. Suppl. 4, pp. S380 . https://doi.org/10.1016/j.annonc.2022.04.445

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5137ea7874d0bd9cfb32e243337a3e8
https://vbn.aau.dk/da/publications/0117ec2a-c071-4c65-b294-385bcdbcb0f6

Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas

Autor: Butt, B P, Stokmo, H L, Ladekarl, M, Tabaksblat, E Mitkina, Sorbye, H, Revheim, M E, Hjortland, G O

Publikováno v: Butt, B P, Stokmo, H L, Ladekarl, M, Tabaksblat, E M, Sorbye, H, Revheim, M E & Hjortland, G O 2021, ' Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas ', Annals of Oncology, vol. 32, no. 5, 1108P, pp. S915-S915 . https://doi.org/10.1016/j.annonc.2021.08.190

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::60076975afc14ad5f5bd21ef59c26a00
https://vbn.aau.dk/da/publications/15f975fb-13f9-4e69-bfb7-eecf79d5fbb6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.